Compare FuelCell Energy Inc (FCEL) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FuelCell Energy Inc vs Eli Lilly And Co — how do they compare? FuelCell Energy Inc trades at $17.62 (market cap $1.47B), while Eli Lilly And Co trades at $1,169 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 707.5× FuelCell Energy Inc's market cap, and Eli Lilly And Co pays a 0.59% dividend while FuelCell Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold FuelCell Energy Inc for 48 Days and Eli Lilly And Co for 93 Days on average.
| FCEL | LLY | |
|---|---|---|
Market Cap | $1.47B | $1.04T |
Volume | 12,559,948 | 3,064,878 |
Sector | Industrials | Health |
52-Week High | $36.01 | $1.28K |
52-Week Low | $6.00 | $799.57 |
Typical Hold Time | 48 Days | 93 Days |
Enterprise Value | $1.05B | $1.09T |
Dividend Yield | — | 0.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCEL stock trades at $18.37, down 11.07% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $158.16M in 2025 but sustained a net loss of $187.90M, reflecting negative profit margins. Recent news highlights a securities class action lawsuit filed against the company, alleging disclosure failures between June and September 2026.
The outlook remains challenged by persistent losses and high cash burn, though analyst consensus suggests a $21.57 price target with 40% buy ratings. Key risks include the class action litigation, execution on profitability, and reliance on financing activities to fund operations.
Eli Lilly (LLY) trades at $1,188.72, up 2.7% on the day, with a bullish technical signal and strong fundamentals. Recent earnings beats, robust revenue growth to $65.18B in 2025, and a net income margin of 33.53% highlight operational strength. Positive news flow centers on next-generation weight-loss drugs, with analyst consensus bullish and a price target of $1,350.
Outlook remains positive given pipeline catalysts in obesity/diabetes markets, though high valuations (P/E 39.9) and rising debt levels pose risks. Competitive intensity and regulatory scrutiny are watchpoints, but institutional support and earnings momentum underpin further upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
